Imprivata (IMPR) Tops Q4 EPS by 1c, Offers Q1 & FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
Imprivata Inc. (IMPR) Seeing Sustainable Growth, Cutting PT - PiperJaffray
February 17, 2016 11:53 AM ESTPiper Jaffray analyst, Sean Wieland, reiterated his Overweight rating on Imprivata (NYSE: IMPR) but cut his PT by $1 as the company posted a mostly in line quarter. The company continues its transition out of the non-hospital markets to focus on its core base but as multiples tighten, the PT pulled back slightly, despite the solid results.
Revenues of $34.2M beat consensus of $33.2M, and non-GAAP EPS of ($0.15) was in line with consensus. Product revenue of $19.9M grew by 20% y/y... More
Leerink Partners Cuts Price Target on Imprivata (IMPR) Following Slight Beat and Weak Guidance
February 17, 2016 7:05 AM ESTLeerink Partners maintained an Outperform rating on Imprivata (NYSE: IMPR), and cut the price target to $13.00 (from $17.00), following the company's 4Q earnings report. Imprivata reported revenue of $34.2m in the quarter, slightly above guidance of $32-34m. Adjusted EPS for the quarter came in at ($0.09),... More
